D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AMED holding history
Amedisys Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMED overviewAll 13F holders of AMEDFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −3,078−100.0% | Sold out | Holders |
| Q2 2024 | 3,078 | $282.6K | <0.1% | −1,414−31.5% | Reduced | Holders |
| Q1 2024 | 4,492 | $414.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 4,492 | $427.0K | <0.1% | −10,881−70.8% | Reduced | Holders |
| Q3 2023 | 15,373 | $1.44M | <0.1% | −190,987−92.6% | Reduced | Holders |
| Q2 2023 | 206,360 | $18.9M | <0.1% | −53,800−20.7% | Reduced | Holders |
| Q1 2023 | 260,160 | $19.1M | <0.1% | +59,291+29.5% | Added | Holders |
| Q4 2022 | 200,869 | $16.8M | <0.1% | +48,092+31.5% | Added | Holders |
| Q3 2022 | 152,777 | $14.8M | <0.1% | −45,624−23.0% | Reduced | Holders |
| Q2 2022 | 198,401 | $20.9M | <0.1% | −103,790−34.3% | Reduced | Holders |
| Q1 2022 | 302,191 | $52.1M | 0.1% | −221,656−42.3% | Reduced | Holders |
| Q4 2021 | 523,847 | $84.8M | 0.1% | −129,301−19.8% | Reduced | Holders |
| Q3 2021 | 653,148 | $97.4M | 0.1% | +272,576+71.6% | Added | Holders |
| Q2 2021 | 380,572 | $93.2M | 0.1% | +60,932+19.1% | Added | Holders |
| Q1 2021 | 319,640 | $84.6M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.